Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
1 clinical trials · Condition
◉ Watch Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06649292) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-11-22 |
Track Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.